Free shipping on all orders over $ 500

Monoamine Oxidase Monoamine Oxidase

Cat.No.  Name Information
M14566 (2-Chloropyridin-4-yl)methanamine hydrochloride (2-Chloropyridin-4-yl)methanamine hydrochloride is a selective LOXL2 inhibitor with an IC50 of 126 nM.
M5783 Methylene Blue Methylene Blue is used as a dye in chromoendoscopy. It Inhibits tau filament formation with IC50 of 1.9μM. Also it inhibits soluble guanylyl cyclase.
M49484 PF9601N PF9601N is a monoamine oxidase B (MAO-B) inhibitor with neuroprotective properties in various ex vivo and in vivo models of Parkinson's disease (PD) for the study of excitotoxicity-mediated neurodegenerative diseases. In addition, PF9601N is a click chemistry reagent containing an Alkyne moiety that undergoes a copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing an Azide moiety.
M30162 Harmol  Harmol is an orally active monoamine oxidase (MAO) inhibitor that has anti-tumor, anti-depressant, and anti-aging effects. Harmol is a TFEB activator. Harmol can induce cell mitosis, autophagy and apoptosis. Harmol promotes the degradation of α-synuclein through the regulation of the autophagy-lysosomal pathway, improving motor deficits in mouse models of Parkinson's disease.
M29602 LOX-IN-3 dihydrochloride  LOX-IN-3 dihydrochloride is an orally active lysyl oxidase (LOX) inhibitor. LOX-IN-3 dihydrochloride can be used for fibrosis, cancer and angiogenesis research.
M29601 LOX-IN-3  LOX-IN-3 is an orally active lysyl oxidase (LOX) inhibitor. LOX-IN-3 can be used for fibrosis, cancer and angiogenesis research.
M29270 PXS-5153A  PXS-5153A is a potent, selective, orally active and fast-acting lysyl oxidase like 2/3 enzymatic (LOXL2/LOXL3) inhibitor, with an IC50 of <40 nM for LOXL2 across all mammalian species and an IC50 of 63 nM for human LOXL3. PXS-5153A could reduce crosslinks and ameliorates fibrosis.
M29269 PXS-5120A  PXS-5120A is a potent, irreversible fluoroallylamine inhibitor of Lysyl Oxidase-like 2/3 (LOXL2/3) with anti-fibrotic activity. PXS-5120A is >300-fold selective for LOXL2 (Ki of 83 nM; pIC50 of 8.4) over LOXL (pIC50 of 5.8).
M24611 Simtuzumab Simtuzumab (AB 0024; GS 6624) is a monoclonal antibody directed against Lysyl oxidase like-2 (LOXL2). Simtuzumab can be used for the research of primary sclerosing cholangitis (PSC).
M19461 Eckol Eckol is a potent hMAO-A (Mixed) and hMAO-B (non-competitive) inhibitor with IC50s of 7.20 and 83.44 μM, respectively. Eckol shows antiallergic and antiviral effects.
M19368 Osthenol Osthenol (Ostenol) is a selective, reversible, and competitive human monoamine oxidase-A (hMAO-A) inhibitor (Ki=0.26 µM). Osthenol potently inhibits recombinant hMAO-A with an IC50 of 0.74 µM and shows a high selectivity index for hMAO-A versus hMAO-B.
M17950 1,7-Dihydroxy-2,3,8-trimethoxy-6-methylanthracene-9,10-dione;Obtusin 1,7-Dihydroxy-2,3,8-trimethoxy-6-methylanthracene-9,10-dione;Obtusin
M14563 4-Hydroxyderricin 4-Hydroxyderricin, the major active ingredients of Angelica keiskei Koidzumi, is a potent selective MAO-B (Monoamine oxidase inhibitors) inhibitor with an IC50 of 3.43 μM.
M10572 Paeonol Paeonol is an active extraction from the root of Paeonia suffruticosa, Paeonol inhibits MAO-A and MAO-B with IC50 of 54.6 μM and 42.5 μM, respectively.
M9663 PXS-4728A PXS-4728A is a selective and orally active semicarbazide-sensitive amine oxidase (SSAO) inhibitor.
M9485 Eprobemide Eprobemide is a non-competitive reversible inhibitor of monoamine oxidase A that exhibits selective action on serotonin deamination.
M9090 Tranylcypromine hemisulfate Tranylcypromine hemisulfate is a nonselective and irreversible inhibitor of the enzyme monoamine oxidase (MAO).
M8804 Toloxatone Toloxadone is a reversible monoamine oxidase A inhibitor (MAOI) and antidepressant compound.
M7919 MDL 72527 MDL 72527 is an inhibitor of polyamine oxidase (spermine oxidase SMO). MDL 72527 shows a lysosomotropic effect. MDL 72527 shows neuroprotective effects.
M6026 Tranylcypromine (2-PCPA) HCl Tranylcypromine HCl is a monoamine oxidase inhibitor, which inhibits CYP2A6 with Ki of 0.08 μM and 0.2 μM in cDNA-expressing microsomes and Human Liver Microsomes, respectively. Tranylcypromine hydrochloride inhibits LSD1, MAO A and MAO B with IC50s of 20.7, 2.3 and 0.95 μM, respectively.




Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.